Rhodes Jason P

Director at DYN; Director at Generation Bio Co.; Director at REPL, and 1 more

Sold, on record
$216M
Dollars the filings state
Form 4 sales
32
Latest Aug 14, 2026
Form 144 notices
0
Proposed sales
Companies
4
Filed as an executive or holder

Companies

Sales by reason

7
Routine
0
Plan not stated
0
No plan
1
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale DYNRoutine
    Apr 22 2026

    Sold 834,302 shares at $19.75 ($16.5M)

    Rhodes Jason P, Director

    10b5-1 planSold 39.4% of holdings ($41.9M position)1.3M shares leftFiling

  2. 2 Form 4 sale DYNRoutine
    Apr 27 +5 days

    Sold 384,549 shares at $18.47 ($7.1M)

    Rhodes Jason P, Director

    10b5-1 planSold 24.2% of holdings ($29.4M position)1.2M shares leftFiling

  3. 3 Form 4 sale DYNRoutine
    Apr 28 +1 day

    Sold 227,337 shares at $18.38 ($4.2M)

    Rhodes Jason P, Director

    10b5-1 planSold 16.4% of holdings ($25.5M position)1.2M shares left0.6x usual sizeFiling

  4. 4 Form 4 sale DYNRoutine
    May 6 +8 days

    Sold 106,723 shares at $18.14 ($1.9M)

    Rhodes Jason P, Director

    10b5-1 planSold 8.6% of holdings ($22.6M position)1.1M shares left0.3x usual sizeFiling

  5. 5 Form 4 sale DYNRoutine
    Jun 25 +50 days

    Sold 267,760 shares at $21.09 ($5.6M)

    Rhodes Jason P, Director

    10b5-1 planSold 19.9% of holdings ($28.4M position)1.1M shares left1.2x usual sizeFiling

  6. 6 Form 4 sale DYNRoutine
    Jun 29 +4 days

    Sold 504,695 shares at $21.23 ($10.7M)

    Rhodes Jason P, Director

    10b5-1 planSold 34.1% of holdings ($31.4M position)975,931 shares left2x usual sizeFiling

  7. 7 Form 4 sale DYNRoutine
    Jul 7 +8 days

    Sold 777,451 shares at $22.97 ($17.9M)

    Rhodes Jason P, Director

    10b5-1 planSold 99.6% of holdings ($17.9M position)2,962 shares left2.9x usual sizeFiling

  8. 8 Form 4 sale DYNUnusual
    Aug 14 +38 days

    Sold 2.6M shares at $25.20 ($65.2M)

    Rhodes Jason P, Director

    10b5-1 planSold 85.8% of holdings ($76M position)428,946 shares left7.9x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (32)

Form 144 notices and Form 4 sales by Rhodes Jason P
Source
Aug 14, 2026DYNDirectorForm 4 sale2.6M$65.2M85.8%UnusualSEC
Jul 7, 2026DYNDirectorForm 4 sale777,451$17.9M99.6%RoutineSEC
Jun 29, 2026DYNDirectorForm 4 sale504,695$10.7M34.1%RoutineSEC
Jun 25, 2026DYNDirectorForm 4 sale267,760$5.6M19.9%RoutineSEC
May 6, 2026DYNDirectorForm 4 sale106,723$1.9M8.6%RoutineSEC
Apr 28, 2026DYNDirectorForm 4 sale227,337$4.2M16.4%RoutineSEC
Apr 27, 2026DYNDirectorForm 4 sale384,549$7.1M24.2%RoutineSEC
Apr 22, 2026DYNDirectorForm 4 sale834,302$16.5M39.4%RoutineSEC
Nov 14, 2024DYNDirectorForm 4 sale782$26k0.1%No planSEC
Mar 1, 2024DYNDirectorForm 4 sale46,534$1.4M5.2%RoutineSEC
Feb 28, 2024DYNDirectorForm 4 sale807,838$19.6M48.3%RoutineSEC
Feb 23, 2024DYNDirectorForm 4 sale500,789$11.3M35.2%RoutineSEC
Feb 20, 2024DYNDirectorForm 4 sale510,152$11.9M7.0%RoutineSEC
Sep 29, 2021Generation Bio Co.DirectorForm 4 sale81,088$2.1M99.3%UnusualSEC
Sep 24, 2021Generation Bio Co.DirectorForm 4 sale134,998$3.5M99.4%UnusualSEC
Jun 24, 2021Generation Bio Co.DirectorForm 4 sale31,008$802k98.1%UnusualSEC
Jun 23, 2021Generation Bio Co.DirectorForm 4 sale185,078$4.6M99.6%UnusualSEC
Apr 14, 2021Generation Bio Co.DirectorForm 4 sale140,682$3.6M100.0%UnusualSEC
Apr 9, 2021Generation Bio Co.DirectorForm 4 sale127,095$3.6M47.5%UnusualSEC
Jan 26, 2021REPLDirectorForm 4 sale5,558$256k0.6%Plan not statedSEC
Dec 18, 2020REPLDirectorForm 4 sale4,319$181k18.3%Plan not statedSEC
Dec 17, 2020REPLDirectorForm 4 sale65,029$2.7M76.9%UnusualSEC
Dec 14, 2020REPLDirectorForm 4 sale103,686$4.5M81.5%UnusualSEC
Dec 9, 2020REPLDirectorForm 4 sale217,362$10M88.0%UnusualSEC
Sep 2, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale30,000$1M24.2%Plan not statedSEC
Aug 4, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale30,000$892k26.8%UnusualSEC
Jul 7, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale30,000$982k30.0%UnusualSEC
Jun 2, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale30,000$666k34.1%UnusualSEC
May 5, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale30,000$646k39.5%UnusualSEC
Apr 7, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale25,000$501k42.4%UnusualSEC
Feb 10, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale50,000$1.5M67.6%UnusualSEC
Jan 6, 2014Epizyme, Inc.President, CFO and TreasurerForm 4 sale10,000$202k71.4%UnusualSEC